We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 2,417

US Data, Cybersecurity and Privacy Issues in M&A Transactions
  • Dechert LLP
  • USA
  • March 23 2017

When evaluating a potential target company, buyersinvestors often underestimate the breadth and depth of diligence that should be done with respect


Chicago-Area Hospitals Abandon Fight to Save Merger from FTC Challenge
  • Holland & Knight LLP
  • USA
  • March 22 2017

After the U.S. Court of Appeals for the Seventh Circuit ruled on Oct. 31, 2016, that the district court's refusal to enjoin the merger of


CFIUS Reform Turns to Food Security
  • Hogan Lovells
  • USA
  • March 20 2017

Congressional efforts to reform the Committee on Foreign Investment in the United States (CFIUS), a U.S. Government interagency committee that


Optum-SCA Merger Could Signal Renewed Payer Interest in Providers
  • McGuireWoods LLP
  • USA
  • March 10 2017

In January, UnitedHealth Group’s health services arm Optum announced it would acquire Surgical Care Affiliates (SCA), one of the nation’s largest and


Wait and See: Investors Yearning to Break Out on Healthcare Deals in 2017
  • FTI Consulting Inc
  • USA
  • March 6 2017

As evidenced by the mood at the 2017 JP Morgan Health Conference in January, a number of uncertainties in the healthcare market are on the minds of


Financial Services 2016 Year-End Report
  • Baker & Hostetler LLP
  • USA
  • March 1 2017

Welcome to the 2016 Year-End Report from BakerHostetler’s Financial Services Industry Team. We


Fundraising After the IPO: Seven Capital-Raising Strategies to Consider for Life Science Companies
  • O'Melveny & Myers LLP
  • USA
  • February 22 2017

In the past five years, hundreds of life science companies have completed IPOs. Given the ongoing need of most life science companies to fund product


FTC study provides guidance on requirements for merger remedies
  • Baker McKenzie
  • USA
  • February 15 2017

Expanding on the FTC's divestiture study in 1999, on 19 January 2017, the FTC issued its second report, The FTC’s Merger Remedies 2006-2012: A Report


2017 Legislative and Regulatory Outlook Contents
  • Hogan Lovells
  • USA
  • February 13 2017

President Donald Trump's victory in the election of 2016 had long coattails, helping Republicans narrowly maintain their majority in the Senate and


Private Equity Summary Report-February 2017
  • Benesch Friedlander Coplan & Aronoff LLP
  • USA
  • February 13 2017

Dealmaking in the healthcare industry tapered a bit in 2016, when compared with 2014 and 2015 activity levels